Is tirzepatide generic?

Short answer:
No, there isn’t a generic version of tirzepatide yet.

Why?
Tirzepatide (sold under the brand name Mounjaro®) is a relatively new drug that was approved by the FDA in 2022. It’s a dual agonist for GLP‑1 and GIP receptors and is specifically formulated to help lower blood glucose and aid weight loss. Because it’s still under patent protection and the manufacturer (Eli Lilly) has exclusive rights to its formulation and distribution, a generic version hasn’t been approved.

What that means for you

• Prescription: You’ll need a prescription for Mounjaro®; there’s no “tirzepatide generic” available on the market yet.
• Insurance & Cost: The brand name may be covered by insurance, but generics are usually cheaper. Check with your insurer to see if Mounjaro® is covered or if there are patient assistance programs.
• Future availability: Generic drug approval typically takes a few years after the original drug’s patent expires or after a company files a “generic equivalent” application. The FDA has not yet approved any generic applicants for tirzepatide as of July 2026. If a generic does get approved, it will likely carry a different brand name and the cost will drop.

If you’re looking for cost‑effective options

• Patient Assistance Programs: Eli Lilly offers a Mounjaro® assistance program that can reduce the cost for eligible patients.
• Insurance copay help: Some insurers provide copay cards or discounts for newer drugs.
• Talk to your prescriber: They can discuss alternatives or supportive therapies that might reduce overall costs.

If you have any other questions—whether about how tirzepatide works, its side effects, or how to manage costs—feel free to ask!